| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.192 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 27.378 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 8.640 | 1.096 | 74 | 128 | 301 | 0 | 0 | 0 | 0 | 64 |
| Gross Profit/Loss - EUR | 18.737 | -1.096 | -74 | -128 | -301 | 0 | 0 | 0 | 0 | -64 |
| Net Profit/Loss - EUR | 17.921 | -1.096 | -74 | -128 | -301 | 0 | 0 | 0 | 0 | -64 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Micaso-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 944 | 72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 40.713 | 40.061 | 396 | 343 | 457 | 448 | 438 | 439 | 438 | 60 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 28.924 | 28.676 | 391 | 338 | 332 | 326 | 318 | 319 | 318 | 0 |
| Cash | 11.789 | 11.385 | 4 | 4 | 125 | 122 | 120 | 120 | 120 | 60 |
| Shareholders Funds | 40.493 | 38.983 | -1.107 | -1.215 | -1.492 | -1.464 | -1.431 | -1.436 | -1.431 | -64 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 0 |
| Debts | 1.164 | 1.150 | 1.503 | 1.557 | 1.949 | 1.912 | 1.869 | 1.875 | 1.869 | 124 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Micaso-Med S.r.l.